Multizine H 2 mg/25 mg/5 mg Tablet
By Multizine H
Rx
10 Tablet in a Strip

Composition
Trihexyphenidyl(2mg) + Thioridazine(25mg) + Trifluoperazine(5mg)

Manufacturer - Triko Pharmaceuticals
152, I.d.c., Inudstrial Area, Rohtak - 124001, Rohtak

Expires on or after
October, 2025

liver
Limited information is available regarding the use of Multizine H 2 mg/25 mg/5 mg Tablet in patients with liver disease. It is advisable to consult your doctor before using this medication if you have liver issues. Based on the available data, it is recommended not to use Multizine H 2 mg/25 mg/5 mg Tablet in patients with liver disease due to safety concerns. It is crucial to seek guidance from a healthcare professional to ensure the proper and safe usage of this medication in such cases.

kidney
There is limited information about using Multizine H 2 mg/25 mg/5 mg Tablet in patients with kidney disease. Please consult your doctor.

alcohol
It is not safe to drink alcohol while taking Multizine H 2 mg/25 mg/5 mg Tablet. It is advisable to avoid alcohol with this medication.

driving
Caution - Driving Multizine H 2 mg/25 mg/5 mg Tablet can cause dizziness, drowsiness, or blurred vision, impacting your driving ability.

pregnancy
Multizine H 2 mg/25 mg/5 mg Tablet may be harmful during pregnancy, based on animal studies. Consult your doctor for a thorough assessment of potential risks versus benefits before taking this medication.

breastfeeding
Multizine H 2 mg/25 mg/5 mg Tablet is not recommended during breastfeeding as it may pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹54
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024